Areteia Therapeutics, Inc is currently conducting asthma trials to investigate the safety, tolerability, and efficacy of the investigational drug dexpramipexole (also called “Dex”) in participants with inadequately controlled severe asthma. Do you or your child have severe asthma? We are seeking volunteers for this paid research study that seeks to improve the way we treat…
Biologics Toolkit puts a spotlight on these innovative medications and the conditions they treat, including severe asthma.
October 2024 marks the 20th anniversary of landmark federal legislation allowing students to self-carry and use their quick-relief asthma inhaler at school.
Learn how you can minimize risk and maximize safety at Halloween when you have a child with a food allergy, asthma or latex allergy.
Allergy & Asthma Network applauds Delaware for a new law that requires insurance companies to cover early introduction of food allergens.
Allergy & Asthma Network is honored to once again earn recognition for its commitment to community outreach, health equity & fostering new nonprofit leadership.
Elijah’s law mandates guidelines for childcare providers, ensuring safer environments for children with food allergies.
In this webinar, learn all about biologics, how they work and who might benefit from using them as a treatment.
In this webinar, learn about new vaccines available, new vaccine guidelines and how to address vaccine hesitancy.
In this webinar, learn more about the consensus statement and the outcomes of the working group.
Now enrolling pediatric and adults for The FLAIR Study on asthma.
Get the facts about recommended vaccines for people with asthma. Work with your healthcare team to stay on track with vaccinations for your family.
End of content
End of content
10304 Eaton Place, Suite 100
Fairfax, VA 22030
Phone: 800-878-4403
Join Our Newsletter
Keep up with the latest news from AAN, right in your inbox! Choose from our eNewsletter, Research or EXHALE newsletters.
🔐 We do not share or sell your information.
Featured Topics & Toolkits
2026 Allergy & Asthma Network | All Rights Reserved
